A Phase 3, Multicentre, Open Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/SVHM/58 (ERM Project ID: 39890)
NMA SSA Reference Number: SSA/18/MonH/565
Monash Health Ref: RES-18-0000-443X
Effective start/end date7/11/196/11/24


  • clinical trial
  • phase 3 study
  • treatment efficacy
  • Crohn's Disease